cardinal health - Search News

News

Solaris, Cardinal

Cardinal Health to buy Solaris Health for $1.9 billion, posts weak results

Cardinal Health said on Tuesday it will buy healthcare management firm Solaris Health for $1.9 billion in cash, as the drug distributor looks to expand its specialty business.

Barron's on MSN · 2d

Cardinal Health Is the S&P 500’s Worst Stock Today. Here’s Why.

The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.

GlobalData on MSN · 2d

Cardinal Health expands urology focus with $1.9bn Solaris Health deal

The acquisition reflects Cardinal’s expanded focus on urology in pursuit of higher growth margin versus drug distribution.

Cardinal Health (NYSE:CAH) Misses Q2 Revenue Estimates

Healthcare distributor and services company Cardinal Health (NYSE:CAH) missed Wall Street’s revenue expectations in Q2 CY2025 ...

Drug Store News2d

Cardinal Health reports Q4, 2025 fiscal year results, raises fiscal year 2026 guidance

Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...

Cardinal Health Q4 Preview: Accelerating Autoimmune, Urology, And Oncology, Buy

Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

20h

Cardinal Health's $1.9 Billion Urology Bet Sends Shares Sliding -- But Could Spark Long-Term Growth

Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...

Modern Distribution Management2d

Cardinal Health Reports Flat 4Q Revenue, Higher Profit and a $1.9B Acquisition

Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty care platform with the acquisition of Solaris Health.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results